NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
23.32
+0.74 (3.28%)
At close: Sep 22, 2026, 4:00 PM EDT
23.70
+0.38 (1.63%)
Pre-market: Sep 23, 2026, 8:14 AM EDT
NAMS Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, NAMS stock has a consensus rating of "Strong Buy" and an average price target of $50.82. The average 1-year stock price forecast is 117.92% higher than the current stock price, while the lowest is $37.74 (+61.84%) and the highest is $59.17 (+153.73%).
Price Target: $50.82 (+117.92%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 12 | 12 | 12 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Reiterates $57 | Buy | Reiterates | $57 | +144.43% | Sep 22, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $58 | Buy | Maintains | $58 | +148.71% | Sep 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 | Buy | Reiterates | $52 | +122.98% | Sep 21, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $50 | Buy | Maintains | $50 | +114.41% | Sep 8, 2026 |
Financial Forecast
Revenue This Year
29.14M
from 22.50M
Increased by 29.51%
Revenue Next Year
140.89M
from 29.14M
Increased by 383.46%
EPS This Year
-1.95
from -1.72
EPS Next Year
-1.61
from -1.95
EPS and Forward PE are based on non-GAAP adjusted numbers.